EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

PURPOSE: We investigated whether expression of epidermal growth factor receptor (EGFR) was associated with survival and disease control in this secondary analysis of a phase II trial of cetuximab+chemoradiation for stage III non-small cell lung cancer. METHODS: Patients received cetuximab weekly bef...

Full description

Saved in:
Bibliographic Details
Main Authors: Komaki, Ritsuko, Paulus, Rebecca, Blumenschein, George R, Curran, Walter J., Robert, Francisco, Thariat, Juliette, Werner-Wasik, Maria, Choy, Hak, Hirsch, Fred R., Ang, K. Kian
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169722/
https://ncbi.nlm.nih.gov/pubmed/25042878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2014.06.012
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items